Hepatitis C: looking at a virus that hasn't been seen

Area of Science:

• Virology
• Molecular Biology
• Hepatology

Background:

• Hepatitis C (HCV) was initially identified in 1974 as non-A, non-B hepatitis, primarily linked to blood transfusions.
• The discovery of HCV marked a significant advancement as the first virus identified through molecular cloning techniques.

Purpose of the Study:

• To detail the molecular cloning and characterization of the Hepatitis C virus.
• To explore the genomic structure and protein functions of HCV.
• To assess the utility of recombinant antigens in serological assays for HCV detection and epidemiology.

Main Methods:

• Molecular cloning of viral cDNA from infectious plasma.
• Analysis of viral RNA and polyprotein sequences for structural similarities to flaviviruses and pestiviruses.
• Production of recombinant HCV proteins for use as antigens in immunoassays.

Main Results:

• HCV identified as a positive-sense RNA virus (~10,000 nucleotides) encoding a polyprotein (~3000 amino acids).
• Viral proteins' functions inferred by analogy with related viruses.
• Immunoassays using recombinant antigens are effective for blood screening and epidemiological studies, despite evolving serological patterns.

Conclusions:

• The genomic heterogeneity of HCV poses a significant challenge for future research and clinical management.
• Molecular cloning provided a novel method for viral discovery, bypassing traditional biological assays.
• Recombinant antigen-based immunoassays are crucial tools for managing HCV infection.